PubRank

A J Boulton

Author PubWeight™ 165.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993 4.43
2 Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999 3.27
3 A feasibility study of the use of continuous subcutaneous insulin infusion in a diabetic clinic: patients' choice of treatment. Diabet Med 1984 2.84
4 Predicting risk of diabetic ketoacidosis in patients using continuous subcutaneous insulin infusion. Br Med J (Clin Res Ed) 1986 2.79
5 Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001 2.60
6 The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia 1992 2.38
7 Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 1999 2.37
8 The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994 2.36
9 Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 1993 2.05
10 The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 2001 1.91
11 Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001 1.82
12 Severe hyperkalaemia and ketoacidosis during routine treatment with an insulin pump. Br Med J (Clin Res Ed) 1985 1.62
13 Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 1983 1.61
14 A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 2001 1.59
15 The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996 1.56
16 The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med 1994 1.53
17 The tactile circumferential discriminator. A new, simple screening device to identify diabetic patients at risk of foot ulceration. Diabetes Care 1997 1.42
18 Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic. Diabet Med 1995 1.41
19 Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 1995 1.40
20 The relationship of static foot structure to dynamic foot function. J Biomech 1997 1.40
21 Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly. J Clin Endocrinol Metab 1996 1.39
22 Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care 1991 1.39
23 Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 1998 1.37
24 Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 1998 1.36
25 A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care 2001 1.34
26 Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989 1.32
27 Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 1991 1.32
28 Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care 1983 1.29
29 Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? Diabetologia 1982 1.25
30 A measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes. Diabet Med 1988 1.24
31 Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia 1989 1.23
32 Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia 2001 1.20
33 Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol 2001 1.19
34 Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia 1996 1.17
35 Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care 2001 1.16
36 Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract 1998 1.16
37 Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 1995 1.16
38 Diabetic thoracic polyradiculopathy presenting as abdominal swelling. Br Med J (Clin Res Ed) 1984 1.12
39 Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med 1994 1.12
40 Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med 1999 1.11
41 Gait abnormalities in diabetic neuropathy. Diabetes Care 1997 1.10
42 Psychological status of diabetic people with or without lower limb disability. Diabetes Res Clin Pract 1996 1.10
43 Do people with diabetes wear their prescribed footwear? Diabet Med 1996 1.08
44 Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes 1994 1.08
45 Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care 1994 1.06
46 Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care 1993 1.06
47 The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care 1985 1.06
48 Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed) 1986 1.06
49 Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 1999 1.06
50 Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol 2000 1.05
51 The Neurometer: validation and comparison with conventional tests for diabetic neuropathy. Diabet Med 1991 1.05
52 The natural history of painful diabetic neuropathy--a 4-year study. Postgrad Med J 1983 1.04
53 Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care 1994 1.03
54 Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad Med J 1994 1.03
55 Lack of knowledge of symptoms of hypoglycaemia by elderly diabetic patients. Age Ageing 1991 1.03
56 The clinical diagnosis of sensory neuropathy in elderly people. Diabet Med 1993 1.02
57 The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1. Diabetologia 1999 1.02
58 A foot care program for diabetic unilateral lower-limb amputees. Diabetes Care 2001 1.01
59 Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Clin Sci (Lond) 2000 0.98
60 Continuous activity monitoring in persons at high risk for diabetes-related lower-extremity amputation. J Am Podiatr Med Assoc 2001 0.97
61 Hypoxic neuropathy: relevance to human diabetic neuropathy. Diabetologia 1990 0.96
62 Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes 1998 0.95
63 Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage? Diabetologia 1987 0.95
64 The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabet Med 1992 0.95
65 Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia 1993 0.94
66 Endoneurial capillary abnormalities in mild human diabetic neuropathy. J Neurol Neurosurg Psychiatry 1992 0.94
67 An analysis of dynamic forces transmitted through the foot in diabetic neuropathy. Diabetes Care 1998 0.93
68 Use of plaster casts in the management of diabetic neuropathic foot ulcers. Diabetes Care 1986 0.93
69 Observations on severe ulnar neuropathy in diabetes. J Diabetes Complications 1998 0.92
70 IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls. J Clin Pathol 1994 0.92
71 Herpesvirus colitis: a new cause of diarrhoea in a patient with Hodgkin's disease. Gut 1982 0.92
72 DCCT: implications for diabetes care in the UK. Diabet Med 1993 0.92
73 Diabetic neuropathies and pain. Clin Endocrinol Metab 1986 0.91
74 Small vessel disease in progressive diabetic neuropathy associated with good metabolic control. J Clin Pathol 1985 0.91
75 Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat. J Anat 1999 0.91
76 Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus. Diabet Med 2001 0.91
77 The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy. Diabet Med 1991 0.90
78 Is resistance to ischaemic conduction failure induced by hypoxia? Diabetologia 1988 0.90
79 Myelinated nerve fibre regeneration in diabetic sensory polyneuropathy: correlation with type of diabetes. Acta Neuropathol 1995 0.90
80 Abnormal foot pressures alone may not cause ulceration. Diabet Med 1989 0.90
81 Impaired vibratory perception and diabetic foot ulceration. Diabet Med 1987 0.90
82 Venous distension in the diabetic neuropathic foot (physical sign of arteriovenous shunting). J R Soc Med 1983 0.90
83 A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy. Pain 1989 0.89
84 Diabetic ketoacidosis associated with outpatient treatment using continuous subcutaneous insulin infusion. Postgrad Med J 1983 0.89
85 Risk factors for non-ischaemic foot ulceration in diabetic nephropathy. Diabet Med 1991 0.89
86 The association between symptomatic sensory neuropathy and body stature in diabetic patients. Diabetes Res Clin Pract 1988 0.89
87 Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus. Clin Sci (Lond) 1993 0.89
88 Plantar pressure measurements and the prevention of ulceration in the diabetic foot. J Bone Joint Surg Br 1985 0.88
89 The histology of diabetic foot ulcers. Diabet Med 1996 0.88
90 The vibratory perception threshold in young diabetic patients: associations with glycemia and puberty. Diabetes Care 1986 0.88
91 Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes. Diabetes Care 1999 0.88
92 Peripheral vascular and nerve function associated with lower limb amputation in people with and without diabetes. Clin Sci (Lond) 2001 0.87
93 Perineurial abnormalities in the spontaneously diabetic dog. Acta Neuropathol 1999 0.86
94 An evaluation of diabetes knowledge amongst general practitioners and senior medical students. Central Manchester Health Authority Working Party on Diabetes Care. Diabet Med 1989 0.86
95 Why bother educating the multi-disciplinary team and the patient--the example of prevention of lower extremity amputation in diabetes. Patient Educ Couns 1995 0.86
96 Experience of continuous subcutaneous insulin infusion in the outpatient management of diabetic teenagers. Diabet Med 1986 0.86
97 Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy. Diabetologia 2008 0.86
98 Postural instability in diabetic neuropathic patients at risk of foot ulceration. Diabet Med 1997 0.85
99 Does peripheral neuropathy invariably accompany nephropathy in type 1 diabetes mellitus? Diabetes Res Clin Pract 1998 0.85
100 Serious, prolonged hypoglycaemia with glibenclamide in a patient with Mendenhall's syndrome. Clin Endocrinol (Oxf) 1993 0.85
101 The pathogenesis of diabetic foot problems: an overview. Diabetes 1997 0.84
102 A comparison of the neurothesiometer and biothesiometer for measuring vibration perception in diabetic patients. Diabetes Res Clin Pract 1993 0.84
103 Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol (Oxf) 1994 0.84
104 The pathophysiology of diabetic foot ulceration. Clin Podiatr Med Surg 1995 0.84
105 Excess maternal history of diabetes in Caucasian and Afro-origin non-insulin-dependent diabetic patients suggests dominant maternal factors in disease transmission. Diabetes Res Clin Pract 1995 0.84
106 Restoring lower limb blood flow improves conduction velocity in diabetic patients. Diabetologia 1995 0.84
107 Update on Charcot neuroarthropathy. Curr Diab Rep 2001 0.83
108 Asymptomatic myocardial ischemia in diabetes and its relationship to diabetic neuropathy: an exercise electrocardiography study in middle-aged diabetic men. Diabetes Care 1986 0.83
109 [Diabetic neuropathy. Current concepts on etiopathogenesis, diagnosis, and treatment]. Gac Med Mex 1995 0.83
110 Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care 2000 0.83
111 A randomised controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating. Diabetologia 1997 0.83
112 Abnormalities of foot pressure in early diabetic neuropathy. Diabet Med 1987 0.83
113 Effect of diabetes mellitus on the cardiovascular responses to induction of anaesthesia and tracheal intubation. Br J Anaesth 1993 0.82
114 A prospective study of contact lens wear in diabetes mellitus. Ophthalmic Physiol Opt 2001 0.81
115 Comparison of risk factors for foot problems in diabetic patients attending teaching hospital outpatient clinics in four different European states. Diabet Med 1994 0.81
116 Genetic and metabolic studies in diabetic neuropathy. Diabetologia 1984 0.81
117 Charcot neuroarthropathy triggered by osteomyelitis and/or surgery. Diabet Med 2008 0.81
118 Activity monitors: should we begin dosing activity as we dose a drug? J Am Podiatr Med Assoc 2001 0.81
119 Use of experimental padded hosiery to reduce abnormal foot pressures in diabetic neuropathy. Diabetes Care 1989 0.81
120 [The diabetic foot]. Khirurgiia (Sofiia) 2001 0.80
121 Rheological and microvascular parameters in diabetic peripheral neuropathy. Clin Sci (Lond) 1996 0.80
122 The potential role of cell adhesion molecules in the pathogenesis of diabetic neuropathy. Diabetologia 1998 0.80
123 The distribution of diabetic neuropathy in a British clinic population. Diabetes Res Clin Pract 1987 0.79
124 Quantitative vibration perception testing in elderly people: an assessment of variability. Age Ageing 1992 0.79
125 Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy? Diabetologia 1992 0.79
126 Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group. J Diabetes Complications 1993 0.79
127 Pathogenesis of foot ulcers and the need for offloading. Horm Metab Res 2005 0.79
128 Transperineurial capillary abnormalities in the sural nerve of patients with diabetic neuropathy. Microvasc Res 1994 0.78
129 Plasma lipoprotein composition and cholesteryl ester transfer from high density lipoproteins to very low density and low density lipoproteins in patients with non-insulin-dependent diabetes mellitus. Diabet Med 1996 0.78
130 A comparative study of the Podotrack, a simple semiquantitative plantar pressure measuring device, and the optical pedobarograph in the assessment of pressures under the diabetic foot. Diabet Med 1999 0.77
131 Clinico-pathological features of postural hypotension in diabetic autonomic neuropathy. Diabet Med 2000 0.77
132 Studies of experimental hosiery in diabetic neuropathic patients with high foot pressures. Diabet Med 1990 0.77
133 Relationship of elevated urinary albumin excretion to components of the metabolic syndrome in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1998 0.77
134 A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. North European Tolrestat Study Group. Diabete Metab 1992 0.77
135 Role of neuropathy and plasma nitric oxide in recurrent neuropathic and neuroischemic diabetic foot ulcers. Wound Repair Regen 2002 0.77
136 Increased mortality due to cardiovascular disease in type 1 diabetic patients transplanted for end-stage renal failure. Diabet Med 1994 0.77
137 Role of experimental socks in the care of the high-risk diabetic foot. A multicenter patient evaluation study. American Group for the Study of Experimental Hosiery in the Diabetic Foot. Diabetes Care 1993 0.77
138 Diet treatment of newly presenting type 2 diabetes improves insulin secretory capacity, but has no effect on insulin sensitivity. Diabet Med 1993 0.77
139 Paranodal structure in diabetic sensory polyneuropathy. Acta Neuropathol 1996 0.77
140 Foot pressure measurements in diabetic and nondiabetic amputees. Diabetes Care 1992 0.77
141 Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence. Drugs 1990 0.77
142 Ambulatory monitoring of the ST segment in diabetic men with and without peripheral neuropathy. Diabet Med 1987 0.77
143 Friends of the oppressed foot? Diabetes Care 2001 0.76
144 Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia 1996 0.76
145 The role of diabetic neuropathy and high plantar pressures in the pathogenesis of foot ulceration. Horm Metab Res 1996 0.76
146 Serum sex-hormone-binding globulin is related to hepatic and peripheral insulin sensitivity but not to beta-cell function in men and women with Type 2 diabetes mellitus. Diabet Med 1998 0.76
147 Mendenhall's syndrome: clues to the aetiology of human diabetic neuropathy. J Neurol Neurosurg Psychiatry 1995 0.75
148 Laterality of lower limb amputation in diabetic patients. Study of 15 636 patients found no influence of laterality on risk of amputation. BMJ 1999 0.75
149 Why 'diabetes and history'? Diabet Med 1994 0.75
150 Measuring subjective symptoms. Diabetes Care 1992 0.75
151 Hypokalaemic periodic paralysis precipitated by diuretic therapy and minor surgery. Postgrad Med J 1982 0.75
152 Cellular and humoral immunity in patients with insulin-dependent diabetes. Lancet 1993 0.75
153 Stump pemphigoid: a new complication of the amputee. Br Med J (Clin Res Ed) 1983 0.75
154 Response to "Topical phenytoin in diabetic foot ulcers". Diabetes Care 1992 0.75
155 An optimistic message for foot problems in diabetes. West J Med 1993 0.75
156 Haemodynamic and plasma vasopressin responses during high-dose fentanyl or sufentanil anaesthesia. Can Anaesth Soc J 1986 0.75
157 Effects of anti-hypertensive agents on albumin excretion in type II diabetic patients. Clin Sci (Lond) 1992 0.75
158 Clinical and biochemical effects of parachlorophenylalanine in a patient with the carcinoid syndrome. Postgrad Med J 1982 0.75
159 Ventricular arrhythmias precipitated by treatment with non-thiazide diuretics. Practitioner 1982 0.75
160 Split-skin grafting in the management of extensive neuropathic ulceration. Diabet Med 1989 0.75
161 Poor vision as a contributory factor in diabetic neuro-arthropathy. Diabetes Res Clin Pract 1997 0.75
162 Laser Doppler flowmetry: in the assessment of peripheral vascular disorders? A preliminary evaluation. Clin Phys Physiol Meas 1986 0.75
163 The annual review: here to stay. Diabet Med 1992 0.75
164 The diabetic foot 1990. Diabet Med 1991 0.75
165 Long term glycaemic control by alternative regimens in a feasibility study of continuous subcutaneous insulin infusion. Diabetes Res 1986 0.75
166 Self-poisoning patterns. Lancet 1982 0.75
167 The diabetic foot and the role of a multidisciplinary clinic. J Wound Care 1996 0.75
168 Neutrophil aldose reductase activity as a potential marker for neuropathy and cataract in diabetes. Diabet Med 1991 0.75
169 The Diabetic Foot 1992. Diabet Med 1992 0.75
170 An extensive primary nodular melanoma of the foot with associated distant metastases: a case report. Foot (Edinb) 2012 0.75
171 Reduced hyperaemic response under the diabetic neuropathic foot. Diabet Med 1988 0.75
172 Diabetic medicine: the southbound migration continues. Diabet Med 1996 0.75
173 Alternative medicine: potential dangers for the diabetic foot. Diabet Med 1993 0.75
174 Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus. Diabet Med 1997 0.75
175 The use of absorbable antibiotic-impregnated calcium sulphate pellets in the management of diabetic foot infections. Diabet Med 2001 0.75
176 The diabetic foot: aetiopathogenesis and management. Diabetes Metab Rev 1993 0.75
177 Reduction of abnormal foot pressures in diabetic neuropathy using a new polymer insole material. Diabetes Care 1984 0.75
178 The use of multiple insulin injection therapy using 'NovoPen' in a routine out-patient setting. Diabetes Res Clin Pract 1989 0.75
179 The optical pedobarograph. Clin Podiatr Med Surg 1993 0.75
180 The Diabetic Foot 1998. Diabet Med 1999 0.75
181 Gustatory sweating in diabetes mellitus. Diabet Med 1996 0.75
182 The diabetic foot 1994. Diabet Med 1995 0.75
183 The diabetic foot 2000. Diabet Med 2000 0.75
184 Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM. Diabetes 1995 0.75
185 Management of foot problems in diabetes. Perit Dial Int 1996 0.75
186 Elevated glycosylated hemoglobin in diabetic neuropathy. Acta Diabetol Lat 1983 0.75
187 Near-normal glycaemic control does not correct abnormal platelet reactivity in diabetes mellitus. Clin Sci (Lond) 1984 0.75
188 Nerve ischaemia-resistance: an early abnormality in diabetes. Diabet Med 1988 0.75
189 Peripheral neuropathy. Clin Podiatr Med Surg 1999 0.75
190 The diabetic foot 1996. Diabet Med 1996 0.75
191 Diabetic medicine. Diabet Med 1994 0.75
192 Improved diabetic control and platelet reactivity. Lancet 1985 0.75
193 Calibration problems with the Biothesiometer. Diabet Med 1990 0.75